Maintenance Rituximab after High-Dose Therapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma

Biol Blood Marrow Transplant. 2017 Nov;23(11):1811-1812. doi: 10.1016/j.bbmt.2017.09.008. Epub 2017 Sep 20.

Authors

Tobias Roider¹, Sascha Dietrich²

Affiliations

¹ Department of Medicine V, University of Heidelberg, Germany.
² Department of Medicine V, University of Heidelberg, Germany. Electronic address: sascha.dietrich@med.uni-heidelberg.de.

PMID: 28939452
DOI: 10.1016/j.bbmt.2017.09.008

No abstract available

Keywords: Autologous stem-cell transplantation; High-dose chemotherapy; Maintenance rituximab; Mantle cell lymphoma.

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Murine-Derived
Hematopoietic Stem Cell Transplantation*
Humans
Lymphoma, Mantle-Cell*
Rituximab
Transplantation, Autologous

Substances

Antibodies, Monoclonal, Murine-Derived
Rituximab